7200AA19APS00013-10: ROUND 10 - LOCAL SOLUTIONS TO HEALTH PRIORITIES IN INDONESIA
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Indonesia USAID-Jakarta notices from 2023.
Indonesia USAID-Jakarta offered grants of up to $5.0 million to the applicants described in the notice. It expected to make about 5 awards worth $25.0 million in total. Applications closed on May 24, 2023.
From the official notice on Grants.gov, last changed May 15, 2023. Checked November 7, 2026.
- Award ceiling$5.0 million
- Total funding$25.0 million
- Expected awards5
- Cost sharingNot required
- Funding typeGrant
Key dates
| Posted | April 20, 2023 |
|---|---|
| Deadline | May 24, 2023 |
| Archived by Grants.gov | June 23, 2023 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Eligibility to submit concept papers will be restricted to local entities in Indonesia who are new and underutilized partners as defined in the NPI-GH APS.
Is this a realistic fit?
- Past USAID Foreign Assistance for Programs Overseas awards averaged $8.7 million; this notice allows up to $5.0 million per award.
- Most of the program's money (54% over five years) went to nonprofits.
- No cost sharing or match is required.
What the grant funds
This program is authorized in accordance with Part 1 of the Foreign Assistance act of 1961, as amended. Through this Round 10 to the New Partners Initiative Global Health Annual Program Statement (APS) No. 7200AA19APS00013, USAID/Indonesia is making a special call for the submission of Concepts focused on Local Solutions to Health Priorities in Indonesia. In Round 10, USAID/Indonesia is requesting the submission of concept papers focused on diversifying USAID’s partner base and supporting local partners to deliver Health and Global Health Security - relevant health outcomes. This Round will utilize modality one (1) of the NPI GH APS for direct awards to new and underutilized organizations that are local entities in Indonesia. USAID anticipates issuing up to five (5) awards under this Round to local entities. ● A concept paper must address no more than one (1) objective as per the Funding Opportunity Description below. ● An organization may submit more than one concept paper (note that each concept paper must be for just one objective). ● Concept papers will be evaluated by objective. ● Concepts are expected to comprehensively address the routine activities listed under each objective. ● For selected concept papers, at least one award is expected to be made per Objective. USAID reserves the right to make more than one award per objective or none for any objective. ● In the instance where a single organization is responsive to multiple objectives, USAID reserves the right to combine objectives into a larger award for efficiency with that single organization. Unless otherwise stated herein, all terms and conditions of the NPI GH APS apply. Issuance Date Round 10: April 20, 2023. Questions Due Date and Time: May 8, 2023; 2:00 PM, Jakarta Time Closing Date and Time to Submit Concept for Round 10: May 24, 2023; 2:00 PM, Jakarta Time Please find the full announcement in Related Document tab.
Who has won USAID Foreign Assistance for Programs Overseas grants before
From fiscal 2021 to 2025, USAID Foreign Assistance for Programs Overseas (98.001) awarded $37 billion across 4,233 grant awards, an average of $8.7 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Miscellaneous Foreign Awardees | District of Columbia | 489 | $6.9 billion |
| Family Health International | North Carolina | 91 | $2.1 billion |
| Catholic Relief Services - United States Conference of Catholic Bishops | Maryland | 128 | $1.2 billion |
| Save the Children Federation, Inc. | Connecticut | 100 | $814 million |
| Research Triangle Institute | North Carolina | 33 | $756 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is 7200AA19APS00013-10 still open?
No. It closed on May 24, 2023.
Who can apply for ROUND 10 - LOCAL SOLUTIONS TO HEALTH PRIORITIES IN INDONESIA?
Indonesia USAID-Jakarta accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for ROUND 10 - LOCAL SOLUTIONS TO HEALTH PRIORITIES IN INDONESIA?
Closed May 24, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $5.0 million each. About $25.0 million in total across about 5 awards.
Who has won USAID Foreign Assistance for Programs Overseas grants before?
The largest recipients over five fiscal years were Miscellaneous Foreign Awardees, Family Health International, Catholic Relief Services - United States Conference of Catholic Bishops. The program made 4,233 awards worth $37 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)